Sat.Apr 20, 2024 - Fri.Apr 26, 2024

Remove biopharma-patients
article thumbnail

The Pillars of Trust: Regulatory Compliance in Patient Engagement

PM360

This is especially relevant in biopharmaceutical patient engagement, where regulatory infractions can have existential consequences. The Unique Challenges of Patient/Pharma Interaction Patient engagement has become a critical component of medical marketing.

article thumbnail

HCP Engagement & Education

PM360

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. ABIGAIL MALLON Chief Patient Experience Officer, VMS BioMarketing Physician burnout is on the rise. The second to increase in patient-oriented communication and support for physicians.

article thumbnail

Prioritizing Safety and Pharmacovigilance in the Age of Innovation

Veeva

There has been a fundamental shift to the safety strategy in the industry, with more companies making the switch to in-house R&D, as is the case for many biopharmas in Korea. It is a one-stop shop for ensuring patient safety in a region with varying needs. Learn more about Vault Safety here.

Safety 52